» Articles » PMID: 9883921

The Influence of Oral Contraceptives on the Risk of Multiple Sclerosis

Overview
Date 1999 Jan 12
PMID 9883921
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the risk of multiple sclerosis in users of combined oral contraceptives.

Design: Cohort study conducted between 1968 and 1996 using diagnostic data supplied by general practitioners

Setting: General practices throughout the United Kingdom.

Population: Royal College of General Practitioners' Oral Contraception Study cohort of initially 46,000 women recruited during the late 1960s.

Methods: Directly standardised incidence rates of multiple sclerosis were calculated for current, former and never-users of oral contraceptives using first ever cases of multiple sclerosis reported by the general practitioners. The standardisation variables were age, parity, social class and smoking history. Five-year survival rates in the different contraceptive groups were calculated using standard life table techniques.

Results: One hundred and fourteen first ever cases of multiple sclerosis had been reported by November 1996 during 564,000 woman-years of observation. The incidence rate in both current and former users was not materially different to that in never-users. Although based on limited evidence there was no suggestion that the five-year survival was affected by a woman's use of combined oral contraceptives.

Conclusions: These findings do not suggest a greatly elevated risk of multiple sclerosis during, or after, use of combined oral contraceptives.

Citing Articles

No association between oral contraceptive exposure and subsequent MS: A population-based nested case-control study in primary care.

Zhang Q, Noyce A, Robson J, Giovannoni G, Marshall C, Dobson R Mult Scler. 2024; 30(9):1221-1226.

PMID: 38877717 PMC: 11660507. DOI: 10.1177/13524585241258691.


Association Between the Risk of Multiple Sclerosis and Dietary Proinflammatory/Anti-Inflammatory Food Intake and Dietary Diversity: A Case-Control Study.

Hatami A, Ahmadi-Khorram M, Keykhaei F, Esfehani A, Nematy M Clin Nutr Res. 2024; 13(1):61-73.

PMID: 38362132 PMC: 10866681. DOI: 10.7762/cnr.2024.13.1.61.


Pregnancy History, Oral Contraceptive Pills Consumption (OCPs), and Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Ghajarzadeh M, Mohammadi A, Shahraki Z, Sahraian M, Mohammadifar M Int J Prev Med. 2022; 13:89.

PMID: 35958357 PMC: 9362753. DOI: 10.4103/ijpvm.IJPVM_299_20.


Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy.

Villaverde-Gonzalez R Degener Neurol Neuromuscul Dis. 2022; 12:1-21.

PMID: 35023987 PMC: 8743861. DOI: 10.2147/DNND.S203406.


Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study.

Mitchell R, Bates K, Wootton R, Harroud A, Richards J, Davey Smith G PLoS Biol. 2020; 18(11):e3000973.

PMID: 33253141 PMC: 7728259. DOI: 10.1371/journal.pbio.3000973.